Andrulis Pharmaceuticals Corp. regulatory update

The Beltsville, Md., company received U.S. Patent No. 5,405,855 covering the use of thalidomide to treat non-insulin-dependent diabetes mellitus. By blocking factors that cause insulin resistance, tha...